GAO Chides FDA For Prioritizing Foreign Inspections Based On Pre-approval Concerns

The Government Accountability Office’s latest assessment of FDA’s foreign drug inspections program takes the agency to task for failing to implement a new prioritization scheme that GAO recommended two years ago.